1
|
Arshad MS, Gulfam S, Zafar S, Jalil NA, Ahmad N, Qutachi O, Chang MW, Singh N, Ahmad Z. Engineering of tetanus toxoid-loaded polymeric microneedle patches. Drug Deliv Transl Res 2023; 13:852-861. [PMID: 36253518 PMCID: PMC9576317 DOI: 10.1007/s13346-022-01249-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/03/2022] [Indexed: 02/08/2023]
Abstract
This study is aimed to fabricate tetanus toxoid laden microneedle patches by using a polymeric blend comprising of polyvinyl pyrrolidone and sodium carboxymethyl cellulose as base materials and sorbitol as a plasticizer. The tetanus toxoid was mixed with polymeric blend and patches were prepared by using vacuum micromolding technique. Microneedle patches were evaluated for physical attributes such as uniformity of thickness, folding endurance, and swelling profile. Morphological features were assessed by optical and scanning electron microscopy. In vitro performance of fabricated patches was studied by using bicinchoninic acid assay (BCA). Insertion ability of microstructures was studied in vitro on model skin parafilm and in vivo in albino rat. In vivo immunogenic activity of the formulation was assessed by recording immunoglobulin G (IgG) levels, interferon gamma (IFN-γ) levels, and T-cell (CD4+ and CD8+) count following the application of dosage forms. Prepared patches, displaying sharp-tipped and smooth-surfaced microstructures, remained intact after 350 ± 36 foldings. Optimized microneedle patch formulation showed ~ 74% swelling and ~ 85.6% vaccine release within an hour. The microneedles successfully pierced parafilm. Histological examination of microneedle-treated rat skin confirmed disruption of epidermis without damaging the underneath vasculature. A significant increase in IgG levels (~ 21%), IFN-γ levels (~ 30%), CD4+ (~ 41.5%), and CD8+ (~ 48.5%) cell count was observed in tetanus vaccine-loaded microneedle patches treated albino rats with respect to control (untreated) group at 42nd day of immunization. In conclusion, tetanus toxoid-loaded microneedle patches can be considered as an efficient choice for transdermal delivery of vaccine without inducing pain commonly experienced with hypodermic needles.
Collapse
Affiliation(s)
| | - Shafaq Gulfam
- Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
| | - Saman Zafar
- Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
| | | | - Nadia Ahmad
- Leicester School of Pharmacy, De Montfort University, Leicester, UK
| | - Omar Qutachi
- Leicester School of Pharmacy, De Montfort University, Leicester, UK
| | - Ming-Wei Chang
- Nanotechnology and Integrated Bioengineering Centre, University of Ulster, Newtownabbey, Northern Ireland, UK
| | - Neenu Singh
- Leicester School of Allied Health Sciences, De Montfort University, Leicester, UK
| | - Zeeshan Ahmad
- Leicester School of Pharmacy, De Montfort University, Leicester, UK.
| |
Collapse
|
2
|
Ahmad H, Ali Chohan T, Mudassir J, Mehta P, Yousef B, Zaman A, Ali A, Qutachi O, Chang MW, Fatouros D, Sohail Arshad M, Ahmad Z. Evaluation of sustained-release in-situ injectable gels, containing naproxen sodium, using in vitro, in silico and in vivo analysis. Int J Pharm 2022; 616:121512. [PMID: 35085730 DOI: 10.1016/j.ijpharm.2022.121512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2021] [Revised: 01/11/2022] [Accepted: 01/21/2022] [Indexed: 11/15/2022]
Abstract
The study aimed to fabricate naproxen sodium loaded in-situ gels of sodium alginate. Different in-situ gel forming solutions of naproxen sodium and sodium alginate were prepared and gel formation was studied in different physiological ions i.e., CaCl2 and Ca-gluconate. The prepared gel formulations were evaluated for different physical attributes such as gelation time, sol-gel fraction, ATR-FTIR spectroscopy and in silico molecular dynamics (MD) simulations. Drug release studies were carried out in a dialysis membrane using USP dissolution basket apparatus-I. In vivo anti-inflammatory studies were performed in Sprague-Dawley rats having carrageenan-induced hind paw inflammation. Higher polymer concentration in formulations resulted in decreased gelation time and an increased gel fraction. The ATR-FTIR and MD simulation revealed H-bonding between the alginate and naproxen sodium at 3500-3200 cm-1 with a RMSD of ∼2.8 Å and binding free energy ΔGpred (GB) = -10.93 kcal/mol. In vitro drug release studies from F8CAG suggested a sustained release of naproxen sodium. In vivo studies revealed a continuous decrease in swelling degree (≈-5.28± 0.210 mm) in inflamed hind paw of Sprague-Dawley rats over 96 h. The in-situ gel forming injectable preparation (F8CAG) offers a sustained release of naproxen sodium in the articular cavity which promises the treatment of chronic inflammatory conditions such as arthritis.
Collapse
Affiliation(s)
- Hassan Ahmad
- Department of Pharmaceutics, Bahauddin Zakariya University, Multan, Pakistan; Faculty of Pharmacy, University of Central Punjab, Lahore, Pakistan
| | - Tahir Ali Chohan
- Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan
| | - Jahanzeb Mudassir
- Department of Pharmaceutics, Bahauddin Zakariya University, Multan, Pakistan
| | - Prina Mehta
- School of Pharmacy, De Montfort University, Leicester, UK
| | - Bushra Yousef
- School of Pharmacy, De Montfort University, Leicester, UK
| | - Aliyah Zaman
- School of Pharmacy, De Montfort University, Leicester, UK
| | - Amna Ali
- School of Pharmacy, De Montfort University, Leicester, UK
| | - Omar Qutachi
- School of Pharmacy, De Montfort University, Leicester, UK
| | - Ming-Wei Chang
- School of Engineering, Ulster University, Co. Antrim, UK
| | | | | | - Zeeshan Ahmad
- School of Pharmacy, De Montfort University, Leicester, UK.
| |
Collapse
|
3
|
Ali A, Zaman A, Sayed E, Evans D, Morgan S, Samwell C, Hall J, Arshad MS, Singh N, Qutachi O, Chang MW, Ahmad Z. Electrohydrodynamic atomisation driven design and engineering of opportunistic particulate systems for applications in drug delivery, therapeutics and pharmaceutics. Adv Drug Deliv Rev 2021; 176:113788. [PMID: 33957180 DOI: 10.1016/j.addr.2021.04.026] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2021] [Revised: 04/20/2021] [Accepted: 04/28/2021] [Indexed: 12/18/2022]
Abstract
Electrohydrodynamic atomisation (EHDA) technologies have evolved significantly over the past decade; branching into several established and emerging healthcare remits through timely advances in the engineering sciences and tailored conceptual process designs. More specifically for pharmaceutical and drug delivery spheres, electrospraying (ES) has presented itself as a high value technique enabling a plethora of different particulate structures. However, when coupled with novel formulations (e.g. co-flows) and innovative device aspects (e.g., materials and dimensions), core characteristics of particulates are manipulated and engineered specifically to deliver an application driven need, which is currently lacking, ranging from imaging and targeted delivery to controlled release and sensing. This demonstrates the holistic nature of these emerging technologies; which is often overlooked. Parametric driven control during particle engineering via the ES method yields opportunistic properties when compared to conventional methods, albeit at ambient conditions (e.g., temperature and pressure), making this extremely valuable for sensitive biologics and molecules of interest. Furthermore, several processing (e.g., flow rate, applied voltage and working distance) and solution (e.g., polymer concentration, electrical conductivity and surface tension) parameters impact ES modes and greatly influence the production of resulting particles. The formation of a steady cone-jet and subsequent atomisation during ES fabricates particles demonstrating monodispersity (or near monodispersed), narrow particle size distributions and smooth or textured morphologies; all of which are successfully incorporated in a one-step process. By following a controlled ES regime, tailored particles with various intricate structures (hollow microspheres, nanocups, Janus and cell-mimicking nanoparticles) can also be engineered through process head modifications central to the ES technique (single-needle spraying, coaxial, multi-needle and needleless approaches). Thus, intricate formulation design, set-up and combinatorial engineering of the EHDA process delivers particulate structures with a multitude of applications in tissue engineering, theranostics, bioresponsive systems as well as drug dosage forms for specific delivery to diseased or target tissues. This advanced technology has great potential to be implemented commercially, particularly on the industrial scale for several unmet pharmaceutical and medical challenges and needs. This review focuses on key seminal developments, ending with future perspectives addressing obstacles that need to be addressed for future advancement.
Collapse
|
4
|
Alwahsh SM, Qutachi O, Starkey Lewis PJ, Bond A, Noble J, Burgoyne P, Morton N, Carter R, Mann J, Ferreira‐Gonzalez S, Alvarez‐Paino M, Forbes SJ, Shakesheff KM, Forbes S. Fibroblast growth factor 7 releasing particles enhance islet engraftment and improve metabolic control following islet transplantation in mice with diabetes. Am J Transplant 2021; 21:2950-2963. [PMID: 33428803 PMCID: PMC8603932 DOI: 10.1111/ajt.16488] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2019] [Revised: 12/20/2020] [Accepted: 01/05/2021] [Indexed: 01/25/2023]
Abstract
Transplantation of islets in type 1 diabetes (T1D) is limited by poor islet engraftment into the liver, with two to three donor pancreases required per recipient. We aimed to condition the liver to enhance islet engraftment to improve long-term graft function. Diabetic mice received a non-curative islet transplant (n = 400 islets) via the hepatic portal vein (HPV) with fibroblast growth factor 7-loaded galactosylated poly(DL-lactide-co-glycolic acid) (FGF7-GAL-PLGA) particles; 26-µm diameter particles specifically targeted the liver, promoting hepatocyte proliferation in short-term experiments: in mice receiving 0.1-mg FGF7-GAL-PLGA particles (60-ng FGF7) vs vehicle, cell proliferation was induced specifically in the liver with greater efficacy and specificity than subcutaneous FGF7 (1.25 mg/kg ×2 doses; ~75-µg FGF7). Numbers of engrafted islets and vascularization were greater in liver sections of mice receiving islets and FGF7-GAL-PLGA particles vs mice receiving islets alone, 72 h posttransplant. More mice (six of eight) that received islets and FGF7-GAL-PLGA particles normalized blood glucose concentrations by 30-days posttransplant, versus zero of eight mice receiving islets alone with no evidence of increased proliferation of cells within the liver at this stage and normal liver function tests. This work shows that liver-targeted FGF7-GAL-PLGA particles achieve selective FGF7 delivery to the liver-promoting islet engraftment to help normalize blood glucose levels with a good safety profile.
Collapse
Affiliation(s)
- Salamah M. Alwahsh
- Centre for Regenerative MedicineUniversity of EdinburghEdinburghUK,Joint MD ProgramCollege of Medicine and Health SciencesPalestine Polytechnic UniversityHebronPalestine
| | - Omar Qutachi
- School of PharmacyUniversity of NottinghamUniversity ParkNottinghamUK
| | | | - Andrew Bond
- BHF Centre for Cardiovascular ScienceUniversity of EdinburghQueen’s Medical Research InstituteEdinburghUK
| | - June Noble
- BHF Centre for Cardiovascular ScienceUniversity of EdinburghQueen’s Medical Research InstituteEdinburghUK
| | - Paul Burgoyne
- BHF Centre for Cardiovascular ScienceUniversity of EdinburghQueen’s Medical Research InstituteEdinburghUK
| | - Nik Morton
- BHF Centre for Cardiovascular ScienceUniversity of EdinburghQueen’s Medical Research InstituteEdinburghUK
| | - Rod Carter
- BHF Centre for Cardiovascular ScienceUniversity of EdinburghQueen’s Medical Research InstituteEdinburghUK
| | - Janet Mann
- Centre for Regenerative MedicineUniversity of EdinburghEdinburghUK
| | | | | | - Stuart J. Forbes
- Centre for Regenerative MedicineUniversity of EdinburghEdinburghUK
| | | | - Shareen Forbes
- BHF Centre for Cardiovascular ScienceUniversity of EdinburghQueen’s Medical Research InstituteEdinburghUK
| |
Collapse
|
5
|
Soroh A, Owen L, Rahim N, Masania J, Abioye A, Qutachi O, Goodyer L, Shen J, Laird K. Microemulsification of essential oils for the development of antimicrobial and mosquito repellent functional coatings for textiles. J Appl Microbiol 2021; 131:2808-2820. [PMID: 34022108 DOI: 10.1111/jam.15157] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2020] [Revised: 04/15/2021] [Accepted: 05/17/2021] [Indexed: 02/01/2023]
Abstract
AIMS To develop an essential oil (EO)-loaded textile coating using an environmentally friendly microemulsion technique to achieve both antimicrobial and mosquito repellent functionalities. METHODS AND RESULTS Minimum inhibitory concentrations and fractional inhibitory concentrations of litsea, lemon and rosemary EOs were determined against Staphylococcus aureus, Escherichia coli, Staphylococcus epidermidis, Pseudomonas aeruginosa and Trichophyton rubrum. A 1 : 2 mixture of litsea and lemon EOs inhibited all the microorganisms tested and was incorporated into a chitosan-sodium alginate assembly by a microemulsification process. The EO-loaded microemulsions were applied to cotton and polyester fabrics using a soak-pad-dry method. The textile challenge tests demonstrated 7-8 log10 reductions of S. epidermidis, S. aureus and E. coli after 24 h and T. rubrum after 48 h. Aedes aegypti mosquito repellency was also assessed which demonstrated 71·43% repellency compared to 52·94% by neat EO-impregnated cotton. CONCLUSIONS Textiles treated with the litsea and lemon EO microemulsion showed strong antimicrobial activity against the skin associated microorganisms E. coli, S. aureus, S. epidermidis and T. rubrum and potential mosquito repellent properties. SIGNIFICANCE AND IMPACT OF THE STUDY EOs could be useful for the development of natural, environmentally friendly functional textiles to protect textiles and users from microbial contamination in addition to possessing other beneficial properties such as mosquito repellency.
Collapse
Affiliation(s)
- A Soroh
- Infectious Disease Research Group, The Leicester School of Pharmacy, De Montfort University, Leicester, UK
| | - L Owen
- Infectious Disease Research Group, The Leicester School of Pharmacy, De Montfort University, Leicester, UK
| | - N Rahim
- Infectious Disease Research Group, The Leicester School of Pharmacy, De Montfort University, Leicester, UK
| | - J Masania
- Technical Services Mass Spectrometry, The Leicester School of Pharmacy, De Montfort University, Leicester, UK
| | - A Abioye
- Pharmaceutical Technologies Research Group, The Leicester School of Pharmacy, De Montfort University, Leicester, UK.,Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, FL, USA
| | - O Qutachi
- Pharmaceutical Technologies Research Group, The Leicester School of Pharmacy, De Montfort University, Leicester, UK
| | - L Goodyer
- Infectious Disease Research Group, The Leicester School of Pharmacy, De Montfort University, Leicester, UK
| | - J Shen
- Textile Engineering and Materials Research Group, School of Fashion and Textiles, De Montfort University, Leicester, UK
| | - K Laird
- Infectious Disease Research Group, The Leicester School of Pharmacy, De Montfort University, Leicester, UK
| |
Collapse
|
6
|
Ali R, Mehta P, Kyriaki Monou P, Arshad MS, Panteris E, Rasekh M, Singh N, Qutachi O, Wilson P, Tzetzis D, Chang MW, Fatouros DG, Ahmad Z. Electrospinning/electrospraying coatings for metal microneedles: A design of experiments (DOE) and quality by design (QbD) approach. Eur J Pharm Biopharm 2020; 156:20-39. [DOI: 10.1016/j.ejpb.2020.08.023] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2020] [Revised: 08/11/2020] [Accepted: 08/24/2020] [Indexed: 01/09/2023]
|
7
|
Nazari K, Mehta P, Arshad MS, Ahmed S, Andriotis EG, Singh N, Qutachi O, Chang MW, Fatouros DG, Ahmad Z. Quality by Design Micro-Engineering Optimisation of NSAID-Loaded Electrospun Fibrous Patches. Pharmaceutics 2019; 12:pharmaceutics12010002. [PMID: 31861296 PMCID: PMC7022274 DOI: 10.3390/pharmaceutics12010002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2019] [Revised: 12/09/2019] [Accepted: 12/12/2019] [Indexed: 02/01/2023] Open
Abstract
The purpose of this study was to apply the Quality by Design (QbD) approach to the electrospinning of fibres loaded with the nonsteroidal anti-inflammatory drugs (NSAIDs) indomethacin (INDO) and diclofenac sodium (DICLO). A Quality Target Product Profile (QTPP) was made, and risk assessments (preliminary hazard analysis) were conducted to identify the impact of material attributes and process parameters on the critical quality attributes (CQAs) of the fibres. A full factorial design of experiments (DoE) of 20 runs was built, which was used to carry out experiments. The following factors were assessed: Drugs, voltage, flow rate, and the distance between the processing needle and collector. Release studies exhibited INDO fibres had greater total release of active drug compared to DICLO fibres. Voltage and distance were found to be the most significant factors of the experiment. Multivariate statistical analytical software helped to build six feasible design spaces and two flexible, universal design spaces for both drugs, at distances of 5 cm and 12.5 cm, along with a flexible control strategy. The current findings and their analysis confirm that QbD is a viable and invaluable tool to enhance product and process understanding of electrospinning for the assurance of high-quality fibres.
Collapse
Affiliation(s)
- Kazem Nazari
- The Leicester School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, UK; (K.N.); (P.M.); (M.S.A.); (S.A.); (O.Q.)
| | - Prina Mehta
- The Leicester School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, UK; (K.N.); (P.M.); (M.S.A.); (S.A.); (O.Q.)
| | - Muhammad Sohail Arshad
- The Leicester School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, UK; (K.N.); (P.M.); (M.S.A.); (S.A.); (O.Q.)
| | - Shahabuddin Ahmed
- The Leicester School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, UK; (K.N.); (P.M.); (M.S.A.); (S.A.); (O.Q.)
| | - Eleftherios G. Andriotis
- Laboratory of Pharmaceutical Technology, Department of Pharmacy, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece;
| | - Neenu Singh
- The School of Allied Health Sciences, De Montfort University, The Gateway, Leicester LE1 9BH, UK;
| | - Omar Qutachi
- The Leicester School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, UK; (K.N.); (P.M.); (M.S.A.); (S.A.); (O.Q.)
| | - Ming-Wei Chang
- Nanotechnology and Integrated Bioengineering Centre, University of Ulster, Jordanstown Campus, Newtownabbey BT37 0QB, Northern Ireland, UK;
| | - Dimitrios G. Fatouros
- Laboratory of Pharmaceutical Technology, Department of Pharmacy, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece;
- Correspondence: (D.G.F.); (Z.A.)
| | - Zeeshan Ahmad
- The Leicester School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, UK; (K.N.); (P.M.); (M.S.A.); (S.A.); (O.Q.)
- Correspondence: (D.G.F.); (Z.A.)
| |
Collapse
|
8
|
Tanase CE, Qutachi O, White LJ, Shakesheff KM, McCaskie AW, Best SM, Cameron RE. Targeted protein delivery: carbodiimide crosslinking influences protein release from microparticles incorporated within collagen scaffolds. Regen Biomater 2019; 6:279-287. [PMID: 31616565 PMCID: PMC6783698 DOI: 10.1093/rb/rbz015] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2019] [Accepted: 03/11/2019] [Indexed: 12/17/2022] Open
Abstract
Tissue engineering response may be tailored via controlled, sustained release of active agents from protein-loaded degradable microparticles incorporated directly within three-dimensional (3D) ice-templated collagen scaffolds. However, the effects of covalent crosslinking during scaffold preparation on the availability and release of protein from the incorporated microparticles have not been explored. Here, we load 3D ice-templated collagen scaffolds with controlled additions of poly-(DL-lactide-co-glycolide) microparticles. We probe the effects of subsequent N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride crosslinking on protein release, using microparticles with different internal protein distributions. Fluorescein isothiocyanate labelled bovine serum albumin is used as a model protein drug. The scaffolds display a homogeneous microparticle distribution, and a reduction in pore size and percolation diameter with increased microparticle addition, although these values did not fall below those reported as necessary for cell invasion. The protein distribution within the microparticles, near the surface or more deeply located within the microparticles, was important in determining the release profile and effect of crosslinking, as the surface was affected by the carbodiimide crosslinking reaction applied to the scaffold. Crosslinking of microparticles with a high proportion of protein at the surface caused both a reduction and delay in protein release. Protein located within the bulk of the microparticles, was protected from the crosslinking reaction and no delay in the overall release profile was seen.
Collapse
Affiliation(s)
- Constantin Edi Tanase
- Department of Materials Science and Metallurgy, University of Cambridge, Cambridge Centre for Medical Materials, Cambridge, 27, Charles Babbage Road, UK
| | - Omar Qutachi
- Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, UK
| | - Lisa J White
- Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, UK
| | - Kevin M Shakesheff
- Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, UK
| | - Andrew W McCaskie
- Division of Trauma & Orthopaedic Surgery, Department of Surgery, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, UK
| | - Serena M Best
- Department of Materials Science and Metallurgy, University of Cambridge, Cambridge Centre for Medical Materials, Cambridge, 27, Charles Babbage Road, UK
| | - Ruth E Cameron
- Department of Materials Science and Metallurgy, University of Cambridge, Cambridge Centre for Medical Materials, Cambridge, 27, Charles Babbage Road, UK
| |
Collapse
|
9
|
Mehta P, Picken H, White C, Howarth K, Langridge K, Nazari K, Taylor P, Qutachi O, Chang M, Ahmad Z. Engineering optimisation of commercial facemask formulations capable of improving skin moisturisation. Int J Cosmet Sci 2019; 41:462-471. [DOI: 10.1111/ics.12560] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2019] [Accepted: 07/14/2019] [Indexed: 12/16/2022]
Affiliation(s)
- P. Mehta
- Leicester School of Pharmacy De Montfort University LeicesterLE1 9BH UK
| | - H. Picken
- Leicester School of Pharmacy De Montfort University LeicesterLE1 9BH UK
| | - C. White
- Leicester School of Pharmacy De Montfort University LeicesterLE1 9BH UK
| | - K. Howarth
- Leicester School of Pharmacy De Montfort University LeicesterLE1 9BH UK
| | - K. Langridge
- Leicester School of Pharmacy De Montfort University LeicesterLE1 9BH UK
| | - K. Nazari
- Leicester School of Pharmacy De Montfort University LeicesterLE1 9BH UK
| | - P. Taylor
- Leicester School of Pharmacy De Montfort University LeicesterLE1 9BH UK
| | - O. Qutachi
- Leicester School of Pharmacy De Montfort University LeicesterLE1 9BH UK
| | - M.‐w. Chang
- Key Laboratory for Biomedical Engineering of Education Ministry of China Zhejiang University Hangzhou 310027P. R. China
- Zhejiang Provincial Key Laboratory of Cardio‐Cerebral Vascular Detection Technology and Medicinal Effectiveness Appraisal College of Biomedical Engineering & Instrument Science Zhejiang University Hangzhou310027P. R. China
- Nanotechnology and Integrated Bioengineering Centre University of Ulster NewtownabbeyBT37 OQBNorthern Ireland UK
| | - Z. Ahmad
- Leicester School of Pharmacy De Montfort University LeicesterLE1 9BH UK
| |
Collapse
|
10
|
Rotherham M, Henstock JR, Qutachi O, El Haj AJ. Remote regulation of magnetic particle targeted Wnt signaling for bone tissue engineering. Nanomedicine: Nanotechnology, Biology and Medicine 2018; 14:173-184. [DOI: 10.1016/j.nano.2017.09.008] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/08/2017] [Revised: 08/14/2017] [Accepted: 09/15/2017] [Indexed: 01/18/2023]
|
11
|
Boukari Y, Qutachi O, Scurr DJ, Morris AP, Doughty SW, Billa N. A dual-application poly (dl-lactic-co-glycolic) acid (PLGA)-chitosan composite scaffold for potential use in bone tissue engineering. J Biomater Sci Polym Ed 2017; 28:1966-1983. [PMID: 28777694 DOI: 10.1080/09205063.2017.1364100] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
The development of patient-friendly alternatives to bone-graft procedures is the driving force for new frontiers in bone tissue engineering. Poly (dl-lactic-co-glycolic acid) (PLGA) and chitosan are well-studied and easy-to-process polymers from which scaffolds can be fabricated. In this study, a novel dual-application scaffold system was formulated from porous PLGA and protein-loaded PLGA/chitosan microspheres. Physicochemical and in vitro protein release attributes were established. The therapeutic relevance, cytocompatibility with primary human mesenchymal stem cells (hMSCs) and osteogenic properties were tested. There was a significant reduction in burst release from the composite PLGA/chitosan microspheres compared with PLGA alone. Scaffolds sintered from porous microspheres at 37 °C were significantly stronger than the PLGA control, with compressive strengths of 0.846 ± 0.272 MPa and 0.406 ± 0.265 MPa, respectively (p < 0.05). The formulation also sintered at 37 °C following injection through a needle, demonstrating its injectable potential. The scaffolds demonstrated cytocompatibility, with increased cell numbers observed over an 8-day study period. Von Kossa and immunostaining of the hMSC-scaffolds confirmed their osteogenic potential with the ability to sinter at 37 °C in situ.
Collapse
Affiliation(s)
- Yamina Boukari
- a School of Pharmacy , The University of Nottingham Malaysia Campus , Semenyih , Malaysia
| | - Omar Qutachi
- b School of Pharmacy , The University of Nottingham, Park Campus , Nottingham , UK
| | - David J Scurr
- b School of Pharmacy , The University of Nottingham, Park Campus , Nottingham , UK
| | - Andrew P Morris
- a School of Pharmacy , The University of Nottingham Malaysia Campus , Semenyih , Malaysia
| | | | - Nashiru Billa
- a School of Pharmacy , The University of Nottingham Malaysia Campus , Semenyih , Malaysia
| |
Collapse
|
12
|
Baki A, Rahman CV, White LJ, Scurr DJ, Qutachi O, Shakesheff KM. Surface modification of PdlLGA microspheres with gelatine methacrylate: Evaluation of adsorption, entrapment, and oxygen plasma treatment approaches. Acta Biomater 2017; 53:450-459. [PMID: 28093368 PMCID: PMC5424780 DOI: 10.1016/j.actbio.2017.01.042] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2016] [Revised: 01/11/2017] [Accepted: 01/12/2017] [Indexed: 11/16/2022]
Abstract
Injectable poly (dl-lactic-co-glycolic acid) (PdlLGA) microspheres are promising candidates as biodegradable controlled release carriers for drug and cell delivery applications; however, they have limited functional groups on the surface to enable dense grafting of tissue specific biocompatible molecules. In this study we have evaluated surface adsorption, entrapment and oxygen plasma treatment as three approaches to modify the surfaces of PdlLGA microspheres with gelatine methacrylate (gel-MA) as a biocompatible and photo cross-linkable macromolecule. Time of flight secondary ion mass spectroscopy (TOF SIMS) and X-ray photoelectron spectroscopy (XPS) were used to detect and quantify gel-MA on the surfaces. Fluorescent and scanning electron microscopies (SEM) were used to image the topographical changes. Human mesenchymal stem cells (hMSCs) of immortalised cell line were cultured on the surface of gel-MA modified PdlLGA microspheres and Presto-Blue assay was used to study the effect of different surface modifications on cell proliferation. Data analysis showed that the oxygen plasma treatment approach resulted in the highest density of gel-MA deposition. This study supports oxygen plasma treatment as a facile approach to modify the surface of injectable PdlLGA microspheres with macromolecules such as gel-MA to enhance proliferation rate of injected cells and potentially enable further grafting of tissue specific molecules. Statement of Significance Poly (dl lactic-co-glycolic) acid (PdlLGA) microspheres offer limited functional groups on their surface to enable proper grafting of tissue specific bioactive molecules. To overcome this limitation, previous approaches have suggested using alkaline solutions to introduce active groups to the surface; however, they may compromise surface topography and lose any potential surface patterns. Plasma polymerisation of bioactive monomers has been suggested to enhance surface biocompatibility; however, it is not applicable on low vapour pressure macromolecules such as most extracellular matrix (ECM) proteins and growth factors. This study aims to evaluate three different approaches to modify the surface of PdlLGA microspheres with gelatine-methacrylate (gel-MA) to enable further grafting of cross-linkable biomolecules without compromising the surface topography or the biocompatibility of the system.
Collapse
Affiliation(s)
- Abdulrahman Baki
- Division of Drug Delivery and Tissue Engineering, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK
| | - Cheryl V Rahman
- Division of Drug Delivery and Tissue Engineering, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK
| | - Lisa J White
- Division of Drug Delivery and Tissue Engineering, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK
| | - David J Scurr
- Laboratory of Biophysics and Surface Analysis, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK
| | - Omar Qutachi
- Division of Drug Delivery and Tissue Engineering, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK
| | - Kevin M Shakesheff
- Division of Drug Delivery and Tissue Engineering, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
| |
Collapse
|
13
|
Kirby GTS, White LJ, Steck R, Berner A, Bogoevski K, Qutachi O, Jones B, Saifzadeh S, Hutmacher DW, Shakesheff KM, Woodruff MA. Microparticles for Sustained Growth Factor Delivery in the Regeneration of Critically-Sized Segmental Tibial Bone Defects. Materials (Basel) 2016; 9:ma9040259. [PMID: 28773384 PMCID: PMC5502923 DOI: 10.3390/ma9040259] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/18/2016] [Revised: 03/18/2016] [Accepted: 03/18/2016] [Indexed: 11/16/2022]
Abstract
This study trialled the controlled delivery of growth factors within a biodegradable scaffold in a large segmental bone defect model. We hypothesised that co-delivery of vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) followed by bone morphogenetic protein-2 (BMP-2) could be more effective in stimulating bone repair than the delivery of BMP-2 alone. Poly(lactic-co-glycolic acid) (PLGA ) based microparticles were used as a delivery system to achieve a controlled release of growth factors within a medical-grade Polycaprolactone (PCL) scaffold. The scaffolds were assessed in a well-established preclinical ovine tibial segmental defect measuring 3 cm. After six months, mechanical properties and bone tissue regeneration were assessed. Mineralised bone bridging of the defect was enhanced in growth factor treated groups. The inclusion of VEGF and PDGF (with BMP-2) had no significant effect on the amount of bone regeneration at the six-month time point in comparison to BMP-2 alone. However, regions treated with VEGF and PDGF showed increased vascularity. This study demonstrates an effective method for the controlled delivery of therapeutic growth factors in vivo, using microparticles.
Collapse
Affiliation(s)
- Giles T S Kirby
- Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Brisban, QLD 4006, Australia.
- School of Pharmacy, University Park, The University of Nottingham, University Park, Nottingham NG7 2RD, UK.
| | - Lisa J White
- School of Pharmacy, University Park, The University of Nottingham, University Park, Nottingham NG7 2RD, UK.
| | - Roland Steck
- Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Brisban, QLD 4006, Australia.
| | - Arne Berner
- Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Brisban, QLD 4006, Australia.
- Department of Trauma Surgery, University of Regensburg, Regensburg 93164, Germany.
| | - Kristofor Bogoevski
- Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Brisban, QLD 4006, Australia.
| | - Omar Qutachi
- School of Pharmacy, University Park, The University of Nottingham, University Park, Nottingham NG7 2RD, UK.
| | - Brendan Jones
- Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Brisban, QLD 4006, Australia.
| | - Siamak Saifzadeh
- Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Brisban, QLD 4006, Australia.
| | - Dietmar W Hutmacher
- Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Brisban, QLD 4006, Australia.
| | - Kevin M Shakesheff
- School of Pharmacy, University Park, The University of Nottingham, University Park, Nottingham NG7 2RD, UK.
| | - Maria A Woodruff
- Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Brisban, QLD 4006, Australia.
| |
Collapse
|
14
|
Gothard D, Smith EL, Kanczler JM, Black CR, Wells JA, Roberts CA, White LJ, Qutachi O, Peto H, Rashidi H, Rojo L, Stevens MM, El Haj AJ, Rose FRAJ, Shakesheff KM, Oreffo ROC. In Vivo Assessment of Bone Regeneration in Alginate/Bone ECM Hydrogels with Incorporated Skeletal Stem Cells and Single Growth Factors. PLoS One 2015; 10:e0145080. [PMID: 26675008 PMCID: PMC4684226 DOI: 10.1371/journal.pone.0145080] [Citation(s) in RCA: 58] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2015] [Accepted: 11/27/2015] [Indexed: 12/21/2022] Open
Abstract
The current study has investigated the use of decellularised, demineralised bone extracellular matrix (ECM) hydrogel constructs for in vivo tissue mineralisation and bone formation. Stro-1-enriched human bone marrow stromal cells were incorporated together with select growth factors including VEGF, TGF-β3, BMP-2, PTHrP and VitD3, to augment bone formation, and mixed with alginate for structural support. Growth factors were delivered through fast (non-osteogenic factors) and slow (osteogenic factors) release PLGA microparticles. Constructs of 5 mm length were implanted in vivo for 28 days within mice. Dense tissue assessed by micro-CT correlated with histologically assessed mineralised bone formation in all constructs. Exogenous growth factor addition did not enhance bone formation further compared to alginate/bone ECM (ALG/ECM) hydrogels alone. UV irradiation reduced bone formation through degradation of intrinsic growth factors within the bone ECM component and possibly also ECM cross-linking. BMP-2 and VitD3 rescued osteogenic induction. ALG/ECM hydrogels appeared highly osteoinductive and delivery of angiogenic or chondrogenic growth factors led to altered bone formation. All constructs demonstrated extensive host tissue invasion and vascularisation aiding integration and implant longevity. The proposed hydrogel system functioned without the need for growth factor incorporation or an exogenous inducible cell source. Optimal growth factor concentrations and spatiotemporal release profiles require further assessment, as the bone ECM component may suffer batch variability between donor materials. In summary, ALG/ECM hydrogels provide a versatile biomaterial scaffold for utilisation within regenerative medicine which may be tailored, ultimately, to form the tissue of choice through incorporation of select growth factors.
Collapse
Affiliation(s)
- David Gothard
- Bone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton, SO16 6YD, United Kingdom
- * E-mail: (DG); (ROCO)
| | - Emma L. Smith
- Bone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton, SO16 6YD, United Kingdom
| | - Janos M. Kanczler
- Bone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton, SO16 6YD, United Kingdom
| | - Cameron R. Black
- Bone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton, SO16 6YD, United Kingdom
| | - Julia A. Wells
- Bone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton, SO16 6YD, United Kingdom
| | - Carol A. Roberts
- Bone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton, SO16 6YD, United Kingdom
| | - Lisa J. White
- Wolfson Centre for Stem Cells, Tissue Engineering and Modelling, School of Pharmacy, University of Nottingham, Centre for Biomolecular Sciences, University Park, Nottingham, NG7 2RD, United Kingdom
| | - Omar Qutachi
- Wolfson Centre for Stem Cells, Tissue Engineering and Modelling, School of Pharmacy, University of Nottingham, Centre for Biomolecular Sciences, University Park, Nottingham, NG7 2RD, United Kingdom
| | - Heather Peto
- Wolfson Centre for Stem Cells, Tissue Engineering and Modelling, School of Pharmacy, University of Nottingham, Centre for Biomolecular Sciences, University Park, Nottingham, NG7 2RD, United Kingdom
| | - Hassan Rashidi
- Wolfson Centre for Stem Cells, Tissue Engineering and Modelling, School of Pharmacy, University of Nottingham, Centre for Biomolecular Sciences, University Park, Nottingham, NG7 2RD, United Kingdom
| | - Luis Rojo
- Department of Materials, Imperial College London, Royal School of Mines, London, SW7 2AZ, United Kingdom
- Department of Bioengineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, United Kingdom
- Institute for Biomedical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, United Kingdom
- Biomaterials, Biomimetics, Biophotonics Research Division, King's College London, Dental Institute, Guy's Hospital, Tower Wing, London Bridge, London SE1 9RT, United Kingdom
| | - Molly M. Stevens
- Department of Materials, Imperial College London, Royal School of Mines, London, SW7 2AZ, United Kingdom
- Department of Bioengineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, United Kingdom
- Institute for Biomedical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, United Kingdom
| | - Alicia J. El Haj
- Institute for Science and Technology in Medicine, Keele University, Guy Hilton Research Centre, Stoke-on-Trent, ST4 7BQ, United Kingdom
| | - Felicity R. A. J. Rose
- Wolfson Centre for Stem Cells, Tissue Engineering and Modelling, School of Pharmacy, University of Nottingham, Centre for Biomolecular Sciences, University Park, Nottingham, NG7 2RD, United Kingdom
| | - Kevin M. Shakesheff
- Wolfson Centre for Stem Cells, Tissue Engineering and Modelling, School of Pharmacy, University of Nottingham, Centre for Biomolecular Sciences, University Park, Nottingham, NG7 2RD, United Kingdom
- Locate Therapeutics Limited, MediCity, Nottingham, NG90 6BH, United Kingdom
| | - Richard O. C. Oreffo
- Bone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton, SO16 6YD, United Kingdom
- * E-mail: (DG); (ROCO)
| |
Collapse
|
15
|
Boukari Y, Scurr DJ, Qutachi O, Morris AP, Doughty SW, Rahman CV, Billa N. Physicomechanical properties of sintered scaffolds formed from porous and protein-loaded poly(DL-lactic-co-glycolic acid) microspheres for potential use in bone tissue engineering. Journal of Biomaterials Science, Polymer Edition 2015; 26:796-811. [DOI: 10.1080/09205063.2015.1058696] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
16
|
Qodratnama R, Serino LP, Cox HC, Qutachi O, White LJ. Formulations for modulation of protein release from large-size PLGA microparticles for tissue engineering. Materials Science and Engineering: C 2015; 47:230-6. [DOI: 10.1016/j.msec.2014.11.003] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2014] [Revised: 10/15/2014] [Accepted: 11/05/2014] [Indexed: 11/30/2022]
|
17
|
Qutachi O, Vetsch JR, Gill D, Cox H, Scurr DJ, Hofmann S, Müller R, Quirk RA, Shakesheff KM, Rahman CV. Injectable and porous PLGA microspheres that form highly porous scaffolds at body temperature. Acta Biomater 2014; 10:5090-5098. [PMID: 25152354 PMCID: PMC4226323 DOI: 10.1016/j.actbio.2014.08.015] [Citation(s) in RCA: 67] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2014] [Revised: 07/19/2014] [Accepted: 08/15/2014] [Indexed: 01/12/2023]
Abstract
Injectable scaffolds are of interest in the field of regenerative medicine because of their minimally invasive mode of delivery. For tissue repair applications, it is essential that such scaffolds have the mechanical properties, porosity and pore diameter to support the formation of new tissue. In the current study, porous poly(dl-lactic acid-co-glycolic acid) (PLGA) microspheres were fabricated with an average size of 84±24μm for use as injectable cell carriers. Treatment with ethanolic sodium hydroxide for 2min was observed to increase surface porosity without causing the microsphere structure to disintegrate. This surface treatment also enabled the microspheres to fuse together at 37°C to form scaffold structures. The average compressive strength of the scaffolds after 24h at 37°C was 0.9±0.1MPa, and the average Young's modulus was 9.4±1.2MPa. Scaffold porosity levels were 81.6% on average, with a mean pore diameter of 54±38μm. This study demonstrates a method for fabricating porous PLGA microspheres that form solid porous scaffolds at body temperature, creating an injectable system capable of supporting NIH-3T3 cell attachment and proliferation in vitro.
Collapse
|
18
|
Gothard D, Smith EL, Kanczler JM, Rashidi H, Qutachi O, Henstock J, Rotherham M, El Haj A, Shakesheff KM, Oreffo ROC. Tissue engineered bone using select growth factors: A comprehensive review of animal studies and clinical translation studies in man. Eur Cell Mater 2014; 28:166-207; discussion 207-8. [PMID: 25284140 DOI: 10.22203/ecm.v028a13] [Citation(s) in RCA: 119] [Impact Index Per Article: 11.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
There is a growing socio-economic need for effective strategies to repair damaged bone resulting from disease, trauma and surgical intervention. Bone tissue engineering has received substantial investment over the last few decades as a result. A multitude of studies have sought to examine the efficacy of multiple growth factors, delivery systems and biomaterials within in vivo animal models for the repair of critical-sized bone defects. Defect repair requires recapitulation of in vivo signalling cascades, including osteogenesis, chondrogenesis and angiogenesis, in an orchestrated spatiotemporal manner. Strategies to drive parallel, synergistic and consecutive signalling of factors including BMP-2, BMP-7/OP-1, FGF, PDGF, PTH, PTHrP, TGF-β3, VEGF and Wnts have demonstrated improved bone healing within animal models. Enhanced bone repair has also been demonstrated in the clinic following European Medicines Agency and Food and Drug Administration approval of BMP-2, BMP-7/OP-1, PDGF, PTH and PTHrP. The current review assesses the in vivo and clinical data surrounding the application of growth factors for bone regeneration. This review has examined data published between 1965 and 2013. All bone tissue engineering studies investigating in vivo response of the growth factors listed above, or combinations thereof, utilising animal models or human trials were included. All studies were compiled from PubMed-NCBI using search terms including 'growth factor name', 'in vivo', 'model/animal', 'human', and 'bone tissue engineering'. Focus is drawn to the in vivo success of osteoinductive growth factors incorporated within material implants both in animals and humans, and identifies the unmet challenges within the skeletal regenerative area.
Collapse
Affiliation(s)
- D Gothard
- Bone and Joint Research Group, Human Development and Health, University of Southampton, School of Medicine, Institute of Developmental Sciences, Mail Point 887, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD,
| | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Smith E, Kanczler J, Gothard D, Roberts C, Wells J, White L, Qutachi O, Sawkins M, Peto H, Rashidi H, Rojo L, Stevens M, El Haj A, Rose F, Shakesheff K, Oreffo R. Evaluation of skeletal tissue repair, part 1: assessment of novel growth-factor-releasing hydrogels in an ex vivo chick femur defect model. Acta Biomater 2014; 10:4186-96. [PMID: 24937137 DOI: 10.1016/j.actbio.2014.06.011] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2014] [Revised: 05/21/2014] [Accepted: 06/09/2014] [Indexed: 01/08/2023]
Abstract
Current clinical treatments for skeletal conditions resulting in large-scale bone loss include autograft or allograft, both of which have limited effectiveness. In seeking to address bone regeneration, several tissue engineering strategies have come to the fore, including the development of growth factor releasing technologies and appropriate animal models to evaluate repair. Ex vivo models represent a promising alternative to simple in vitro systems or complex, ethically challenging in vivo models. We have developed an ex vivo culture system of whole embryonic chick femora, adapted in this study as a critical size defect model to investigate the effects of novel bone extracellular matrix (bECM) hydrogel scaffolds containing spatio-temporal growth factor-releasing microparticles and skeletal stem cells on bone regeneration, to develop a viable alternative treatment for skeletal degeneration. Alginate/bECM hydrogels combined with poly (d,l-lactic-co-glycolic acid) (PDLLGA)/triblock copolymer (10-30% PDLLGA-PEG-PDLLGA) microparticles releasing VEGF, TGF-β3 or BMP-2 were placed, with human adult Stro-1+ bone marrow stromal cells, into 2mm central segmental defects in embryonic chick femurs. Alginate/bECM hydrogels loaded with HSA/VEGF or HSA/TGF-β3 demonstrated a cartilage-like phenotype, with minimal collagen I deposition, comparable to HSA-only control hydrogels. The addition of BMP-2 releasing microparticles resulted in enhanced structured bone matrix formation, evidenced by increased Sirius red-stained matrix and collagen expression within hydrogels. This study demonstrates delivery of bioactive growth factors from a novel alginate/bECM hydrogel to augment skeletal tissue formation and the use of an organotypic chick femur defect culture system as a high-throughput test model for scaffold/cell/growth factor therapies for regenerative medicine.
Collapse
|
20
|
Smith EL, Kanczler JM, Gothard D, Roberts CA, Wells JA, White LJ, Qutachi O, Sawkins MJ, Peto H, Rashidi H, Rojo L, Stevens MM, El Haj AJ, Rose FRAJ, Shakesheff KM, Oreffo ROC. Evaluation of skeletal tissue repair, part 2: enhancement of skeletal tissue repair through dual-growth-factor-releasing hydrogels within an ex vivo chick femur defect model. Acta Biomater 2014; 10:4197-205. [PMID: 24907660 DOI: 10.1016/j.actbio.2014.05.025] [Citation(s) in RCA: 45] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2014] [Revised: 05/03/2014] [Accepted: 05/23/2014] [Indexed: 11/29/2022]
Abstract
There is an unmet need for improved, effective tissue engineering strategies to replace or repair bone damaged through disease or injury. Recent research has focused on developing biomaterial scaffolds capable of spatially and temporally releasing combinations of bioactive growth factors, rather than individual molecules, to recapitulate repair pathways present in vivo. We have developed an ex vivo embryonic chick femur critical size defect model and applied the model in the study of novel extracellular matrix (ECM) hydrogel scaffolds containing spatio-temporal combinatorial growth factor-releasing microparticles and skeletal stem cells for bone regeneration. Alginate/bovine bone ECM (bECM) hydrogels combined with poly(d,l-lactic-co-glycolic acid) (PDLLGA)/triblock copolymer (10-30% PDLLGA-PEG-PLDLGA) microparticles releasing dual combinations of vascular endothelial growth factor (VEGF), chondrogenic transforming growth factor beta 3 (TGF-β3) and the bone morphogenetic protein BMP2, with human adult Stro-1+bone marrow stromal cells (HBMSCs), were placed into 2mm central segmental defects in embryonic day 11 chick femurs and organotypically cultured. Hydrogels loaded with VEGF combinations induced host cell migration and type I collagen deposition. Combinations of TGF-β3/BMP2, particularly with Stro-1+HBMSCs, induced significant formation of structured bone matrix, evidenced by increased Sirius red-stained matrix together with collagen expression demonstrating birefringent alignment within hydrogels. This study demonstrates the successful use of the chick femur organotypic culture system as a high-throughput test model for scaffold/cell/growth factor therapies in regenerative medicine. Temporal release of dual growth factors, combined with enriched Stro-1+HBMSCs, improved the formation of a highly structured bone matrix compared to single release modalities. These studies highlight the potential of a unique alginate/bECM hydrogel dual growth factor release platform for bone repair.
Collapse
Affiliation(s)
- E L Smith
- Bone & Joint Research Group, Human Development and Health, Institute of Developmental Sciences, University of Southampton, Southampton, UK.
| | - J M Kanczler
- Bone & Joint Research Group, Human Development and Health, Institute of Developmental Sciences, University of Southampton, Southampton, UK
| | - D Gothard
- Bone & Joint Research Group, Human Development and Health, Institute of Developmental Sciences, University of Southampton, Southampton, UK
| | - C A Roberts
- Bone & Joint Research Group, Human Development and Health, Institute of Developmental Sciences, University of Southampton, Southampton, UK
| | - J A Wells
- Bone & Joint Research Group, Human Development and Health, Institute of Developmental Sciences, University of Southampton, Southampton, UK
| | - L J White
- The Wolfson Centre for Stem Cells, Tissue Engineering & Modelling (STEM), School of Pharmacy, University of Nottingham, Nottingham, UK
| | - O Qutachi
- The Wolfson Centre for Stem Cells, Tissue Engineering & Modelling (STEM), School of Pharmacy, University of Nottingham, Nottingham, UK
| | - M J Sawkins
- The Wolfson Centre for Stem Cells, Tissue Engineering & Modelling (STEM), School of Pharmacy, University of Nottingham, Nottingham, UK
| | - H Peto
- The Wolfson Centre for Stem Cells, Tissue Engineering & Modelling (STEM), School of Pharmacy, University of Nottingham, Nottingham, UK
| | - H Rashidi
- The Wolfson Centre for Stem Cells, Tissue Engineering & Modelling (STEM), School of Pharmacy, University of Nottingham, Nottingham, UK
| | - L Rojo
- Department of Materials, Imperial College London, London, UK; Institute for Biomedical Engineering, Imperial College London, London, UK; Institute of Polymer Science & Technology, CSIC and CIBER-BBN, Madrid, Spain
| | - M M Stevens
- Department of Materials, Imperial College London, London, UK; Institute for Biomedical Engineering, Imperial College London, London, UK; Department of Bioengineering, Imperial College London, London, UK
| | - A J El Haj
- Institute for Science and Technology in Medicine, School of Medicine, Keele University, Newcastle-under-Lyme, UK
| | - F R A J Rose
- The Wolfson Centre for Stem Cells, Tissue Engineering & Modelling (STEM), School of Pharmacy, University of Nottingham, Nottingham, UK
| | - K M Shakesheff
- The Wolfson Centre for Stem Cells, Tissue Engineering & Modelling (STEM), School of Pharmacy, University of Nottingham, Nottingham, UK.
| | - R O C Oreffo
- Bone & Joint Research Group, Human Development and Health, Institute of Developmental Sciences, University of Southampton, Southampton, UK.
| |
Collapse
|
21
|
Qutachi O, Shakesheff KM, Buttery LD. Delivery of definable number of drug or growth factor loaded poly(dl-lactic acid-co-glycolic acid) microparticles within human embryonic stem cell derived aggregates. J Control Release 2013; 168:18-27. [DOI: 10.1016/j.jconrel.2013.02.029] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2012] [Revised: 02/14/2013] [Accepted: 02/24/2013] [Indexed: 10/27/2022]
|
22
|
White LJ, Kirby GTS, Cox HC, Qodratnama R, Qutachi O, Rose FRAJ, Shakesheff KM. Accelerating protein release from microparticles for regenerative medicine applications. Mater Sci Eng C Mater Biol Appl 2013; 33:2578-83. [PMID: 23623071 PMCID: PMC3654200 DOI: 10.1016/j.msec.2013.02.020] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/23/2012] [Revised: 02/06/2013] [Accepted: 02/13/2013] [Indexed: 11/20/2022]
Abstract
There is a need to control the spatio-temporal release kinetics of growth factors in order to mitigate current usage of high doses. A novel delivery system, capable of providing both structural support and controlled release kinetics, has been developed from PLGA microparticles. The inclusion of a hydrophilic PLGA–PEG–PLGA triblock copolymer altered release kinetics such that they were decoupled from polymer degradation. A quasi zero order release profile over four weeks was produced using 10% w/w PLGA–PEG–PLGA with 50:50 PLGA whereas complete and sustained release was achieved over ten days using 30% w/w PLGA–PEG–PLGA with 85:15 PLGA and over four days using 30% w/w PLGA–PEG–PLGA with 50:50 PLGA. These three formulations are promising candidates for delivery of growth factors such as BMP-2, PDGF and VEGF. Release profiles were also modified by mixing microparticles of two different formulations providing another route, not previously reported, for controlling release kinetics. This system provides customisable, localised and controlled delivery with adjustable release profiles, which will improve the efficacy and safety of recombinant growth factor delivery.
Collapse
Affiliation(s)
- Lisa J White
- School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
| | | | | | | | | | | | | |
Collapse
|
23
|
Daniel M, Chessman R, Al-Zahid S, Richards B, Rahman C, Ashraf W, McLaren J, Cox H, Qutachi O, Fortnum H, Fergie N, Shakesheff K, Birchall JP, Bayston RR. Biofilm Eradication With Biodegradable Modified-Release Antibiotic Pellets. ACTA ACUST UNITED AC 2012; 138:942-9. [DOI: 10.1001/archotol.2013.238] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
24
|
Bible E, Qutachi O, Chau DYS, Alexander MR, Shakesheff KM, Modo M. Neo-vascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles. Biomaterials 2012; 33:7435-46. [PMID: 22818980 DOI: 10.1016/j.biomaterials.2012.06.085] [Citation(s) in RCA: 109] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2012] [Accepted: 06/28/2012] [Indexed: 12/29/2022]
Abstract
Replacing the tissue lost after a stroke potentially provides a new neural substrate to promote recovery. However, significant neurobiological and biotechnological challenges need to be overcome to make this possibility into a reality. Human neural stem cells (hNSCs) can differentiate into mature brain cells, but require a structural support that retains them within the cavity and affords the formation of a de novo tissue. Nevertheless, in our previous work, even after a week, this primitive tissue is void of a vasculature that could sustain its long-term viability. Therefore, tissue engineering strategies are required to develop a vasculature. Vascular endothelial growth factor (VEGF) is known to promote the proliferation and migration of endothelial cells during angio- and arteriogenesis. VEGF by itself here did not affect viability or differentiation of hNSCs, whereas growing cells on poly(D,L-lactic acid-co-glycolic acid) (PLGA) microparticles, with or without VEGF, doubled astrocytic and neuronal differentiation. Secretion of a burst and a sustained delivery of VEGF from the microparticles in vivo attracted endothelial cells from the host into this primitive tissue and in parts established a neovasculature, whereas in other parts endothelial cells were merely interspersed with hNSCs. There was also evidence of a hypervascularization indicating that further work will be required to establish an adequate level of vascularization. It is therefore possible to develop a putative neovasculature within de novo tissue that is forming inside a tissue cavity caused by a stroke.
Collapse
Affiliation(s)
- Ellen Bible
- Kings College London, Institute of Psychiatry, Department of Neuroscience, London, UK
| | | | | | | | | | | |
Collapse
|